The device got federal Food and Drug Administration clearance this month, marking the end of the FDA approval cycle and the move toward commercialization of an idea that was hatched many years ago.
About four years ago, Analogic partnered on the technology with a privately held company called PocketSonics of Charlottesville, Va. In September 2013, Analogic acquired the remaining ownership stake in the company.
Analogic has “not quantified the revenue potential” of Sonic Window, but Peechatka said a study estimates that there are 300 to 500 million IV placements a year in the United States. About one in three attempts fail in adults without guidance, Peechatka said. One in two attempts fail in pediatrics.
Success rates rise from 82 percent for traditional IV placement methods to 97 percent when these attempts are image guided, Analogic says.
Plans are to market the device this summer to hospitals and emergency rooms, with plans to seek approval of European regulators in the future.
Staff writer Ethan Forman can be reached at 978-338-2673, by email at firstname.lastname@example.org or on Twitter at @DanverSalemNews.